Edition:
United States

People: Trovagene Inc (TROV.OQ)

TROV.OQ on NASDAQ Stock Exchange Capital Market

0.83USD
14 Aug 2018
Change (% chg)

$0.01 (+1.37%)
Prev Close
$0.82
Open
$0.82
Day's High
$0.83
Day's Low
$0.82
Volume
10,127
Avg. Vol
122,547
52-wk High
$12.96
52-wk Low
$0.65

Markin, Rodney 

Dr. Rodney S. Markin, M.D., Ph.D. is Independent Director of Trovagene, Inc. Dr. Markin is Chief Technology Officer and Associate Vice Chancellor for Business Development at the University of Nebraska Medical Center and a Professor of Pathology and Microbiology; David T. Purtilo Distinguished Professor Pathology and Microbiology and Courtesy Professor of Surgery. Dr. Markin is also a director on the Board of Children’s Hospital and Medical Center Foundation and on the Board of Trustees for Keck Graduate Institute and on the Board of the Make-A-Wish Foundation. The Board selected Dr. Markin to serve as a director because he has valuable executive experience in the healthcare business.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --